Publication details
Monitoring bezpečnosti léčby risperidonem u dětí a adolescentů
| Title in English | Safety monitoring of the treatment with risperidone in children and adolescents |
|---|---|
| Authors | |
| Year of publication | 2013 |
| Type | Article in Periodical |
| Magazine / Source | Psychiatrie pro praxi |
| MU Faculty or unit | |
| Citation | |
| Field | Psychiatry, sexuology |
| Keywords | risperidone; metabolic; neurological; extrapyramidal side effects; monitoring |
| Description | Risperidone is an atypic antipsychotic frequently used in children. Risperidone was found to be beneficial and safe in low doses in the treatment of conduct disorders in children and adolescents. Studies in children report significant weight gain and increase in BMI, extrapyramidal side effects and variable elevation in prolactin levels, especially in long term risperidone use. Guidelines of Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in Children (CAMESA) are specifically focused on metabolic and neurological side effects, and how they should be monitored. |